Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BGB-21447 |
Synonyms | |
Therapy Description |
Limited information is currently available on BGB-21447, a putative BCL2 inhibitor (Mar 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BGB-21447 | BGB 21447|BGB21447 | BCL2 inhibitor 27 | Limited information is currently available on BGB-21447, a putative BCL2 inhibitor (Mar 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05828589 | Phase I | BGB-21447 | A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies | Recruiting | AUS | 1 |